MORE►
UTSW
Jean-Laurent Casanova, M.D., Ph.D. [Photo: UTSW]
French Researcher Joining UTSW Is Among Recipients of Up to $25M Cancer Grand Challenges Award
by Sandra Engelland | Mar 11, 2026
The Cancer Grand Challenges initiative, co-founded in 2020 by the National Cancer Institute and Cancer Research UK, provides funding over approximately five years to interdisciplinary teams addressing some of the most complex research questions surrounding cancer.
by Sandra Engelland |
Jan 21, 2026
Zhijian “James” Chen is receiving the prize for his discoveries about the immune system, including cGAS, which "acts as the body’s burglar alarm to trigger defense from invading pathogens," UTSW said. Numerous winners of the Japan Prize have gone on to win the Nobel Prize for their achievements.
MORE►
by Sandra Engelland |
Dec 11, 2025
InterAct, which launched inside BioLabs at Pegasus Park, is a preclinical stage biotech company developing AAV8-based gene therapies for metastatic cancer, with an initial focus on breast cancer-derived liver metastases.
MORE►
by Lance Murray |
Jun 16, 2025
The protein—implicated in blood cancers like leukemia, lymphoma, and multiple myeloma—was decoded in near-atomic detail by UT Southwestern researchers, including Nobel Prize winner Bruce Beutler. In lab models, turning off midnolin wiped out up to 92% of cancer cells—with minimal impact on healthy ones, according to UT Southwestern.
MORE►
UT Southwestern's Clements University Hospital [Photo: UTSW]
UTSW Partners on Study That Could Lead to Earlier Detection of Ovarian Cancer
by Lance Murray | Jun 17, 2024
Researchers at Children's Hospital of Philadelphia and UT Southwestern analyzed T-cell receptors in nearly 500 blood samples from pre-diagnostic patients with ovarian cancer. The results point to the potential of testing for biomarkers 2 to 4 years before most cases of HGOC are currently diagnosed.
MORE►
by Quincy Preston |
Dec 30, 2022
As one of the nation’s premier academic medical centers, nurturing employees for management and leadership roles is mission critical. The medical center, with its workforce of nearly 23,000, received the 2022 BOLD award for its leadership development.
“As we do with our scientific, medical, and training missions, we apply data-driven strategies to nurture leaders who contribute to our institution’s culture of integrity, inclusiveness, and collaboration, and extend those qualities throughout the organization,” Holly Crawford said.
MORE►
by David Seeley |
Dec 20, 2022
The early-stage startup's QmTRIAGE software platform uses AI and machine learning to detect early breast cancers with a "high rate" of accuracy, MedCognetics says. The company has worked with UT Southwestern and UT Dallas to ensure its AI improves outcomes for "all ethnicities," at a time when racial disparities in AI have become a growing concern.
MORE►
by Lance Murray |
Sep 28, 2022
Over 150 scientists across dozens of departments will be part of the elite National Institutes of Health-funded, university-wide interdisciplinary research center. Dallas' UT Southwestern Medical Center is the only institution in Texas to be selected for the NIH initiative.
UTSW wants to translate scientific discoveries into new therapeutic strategies for the prevention and treatment of obesity, which it describes as a chronic disease affecting more than 40% of the U.S. population, with medical costs nearing $175 billion.
UTSW wants to translate scientific discoveries into new therapeutic strategies for the prevention and treatment of obesity, which it describes as a chronic disease affecting more than 40% of the U.S. population, with medical costs nearing $175 billion.
MORE►
[Rendering: UTD]
UT Dallas, UT Southwestern Break Ground on TI-Funded Bioengineering Facility
by Alex Edwards | Nov 15, 2021
The $120 million Texas Instruments Biomedical Engineering and Sciences Building, supported by a gift from Dallas-based Texas Instruments, will focus on advancing transformational bioengineering research that can find solutions to unmet medical needs. It's set to open in 2023.
MORE►
by Quincy Preston |
May 13, 2021
Scientist Chen Liu and his colleagues published new findings that suggest a way to counteract the extra weight that can lead patients to stop taking their medication. Possibilities include a recently FDA-approved drug to treat genetic obesity.
MORE►
by Michaela Markels |
Mar 3, 2021
Aaron Fritts, an interventional radiologist, and Gopi Shah, an otolaryngologist, co-founded BackTable in 2016 as a platform for the exchange of ideas, with the hope that it would propel healthcare into the future. Since, the startup has grown to include a podcast that has skyrocketed during the pandemic in terms of demand, scope of expertise, and impact.
MORE►
by Alexa Vickaryous |
Feb 24, 2021
The scientist's research indicates that exercise can reverse thin bones caused by old age, highlighting the importance of older patients staying active.
MORE►
R.A. Session II, CEO and co-founder of Taysha Gene Therapies [Background image: Olena Yepifanova via iStock]
Taysha and UTSW Launch Innovation Fund to Advance the Development of New Gene Therapies
by Alex Edwards | Jan 13, 2021
The expanded alliance between Taysha and UTSW, which dates back to when Taysha emerged from stealth in April 2020, will support the discovery of novel gene therapy candidates and technologies in new disease areas.
MORE►
![This year’s winners from UT Southwestern —Olutoyosi “Toy” Ogunkua, M.D., Luis Sifuentes-Dominguez, M.D, and Chika Nwachukwu, M.D., Ph.D.—bring the total number grants awarded by the Council since its founding five years ago to nine. [Images via UTSW]](https://s24806.pcdn.co/wp-content/uploads/2021/01/UTSW-investigators-360x203.jpg)
by Alex Edwards |
Jan 11, 2021
Members raised nearly $100K in funding for the research awardees who will investigate new evidence-based pathways that can treat some of the world’s most intractable illnesses.
MORE►
by Dave Moore |
Oct 12, 2020
"The downside of a pandemic is that it's frightening. The good thing is, sometimes it speeds up things that probably needed to happen. Like telemedicine," Nicole Small, CEO of LH Capital/Lyda Hill Philanthropies, said during the event.
MORE►
by Quincy Preston |
Oct 8, 2020
This year's Nobel Prize in Chemistry, awarded to two female scientists for the development of CRISPR as a gene-editing tool, is a revolution, according to a pair of UTSW scientists.
UTSW's Eric Olson and Rhonda Bassel-Duby use the technology in their work to treat Duchenne muscular dystrophy. Olson also is the co-founder of biotech Exonics Therapeutics, which exited last year in a deal roughly valued at $1B.
MORE►
